zentalis
pharmaceuticals
participate
two
upcoming
investor
conferences
new
york
san
diego
globe
newswire
zentalis
pharmaceuticals
nasdaq
zntl
biopharmaceutical
company
focused
discovering
developing
small
molecule
therapeutics
targeting
fundamental
biological
pathways
cancers
today
announced
anthony
sun
md
chairman
chief
executive
officer
zentalis
participate
two
upcoming
virtual
investor
conferences
presentation
details
event
morgan
stanley
annual
global
healthcare
conference
date
thursday
september
time
et
event
cantor
fitzgerald
virtual
global
healthcare
conference
date
thursday
september
time
et
live
webcasts
morgan
stanley
cantor
fireside
chats
accessible
investors
section
company
website
following
events
archived
webcasts
available
zentalis
website
zentalis
zentalis
pharmaceuticals
biopharmaceutical
company
focused
discovering
developing
small
molecule
therapeutics
targeting
fundamental
biological
pathways
cancers
company
developing
broad
pipeline
potentially
oncology
candidates
including
oral
selective
estrogen
receptor
degrader
serd
breast
cancer
inhibitor
inhibitor
egfr
inhibitor
zentalis
operations
new
york
san
diego
information
please
visit
follow
zentalis
twitter
zentalisp
linkedin
company
investor
contact
thomas
hoffmann
solebury
trout
thoffmann
